The Russian Federal Biomedical Agency (FMBA) has announced the development of the drug to treat the new type of coronavirus.
It has been announced that the results of drug and vaccine studies that have been studied for a long time against coronavirus started in Russia by China. In a written statement by the Russian Federal Biomedical Agency (FMBA), Russia ‘FMZ’s’ Farmzashchita’ Research and Production Center has developed the treatment scheme for coronavirus infection on the basis of Meflokin drug used against malaria, taking into account the experience of China and France. . The drug of high selectivity removes the microscopic changes observed in cell cultures following its infection in the coronavirus and prevents a new bacterial viral formation and increases immunity. This drug will provide an effective treatment against the virus in the lungs. ”
No information has yet been provided on when the drug will be released and used on patients.